#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14242	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2071	681.2	0	.	n	.	0	C207T	SNP	207	207	C	481	481	T	756	T,C	504,201	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14242	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2071	681.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1458	1458	C	824	C	772	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25888	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3692	699.1	0	.	n	.	0	T695C	SNP	695	695	T	1041	1041	C	786	C	735	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25888	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3692	699.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2317	2317	C	816	C,T	766,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25888	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3692	699.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2391	2391	A	862	A	811	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25888	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3692	699.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2943	2943	C	760	C	713	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25888	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3692	699.1	0	HET	.	.	.	A1638G	.	1638	1638	A	1984	1984	A	806	A,G	385,382	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1956	folP	855	855	100.0	folP.l15.c4.ctg.1	1446	134.1	1	SNP	p	R229S	1	.	.	685	687	AGC	967	969	AGC	196;197;199	A,G;G;C	182,1;186;186	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5026	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3412	146.5	1	SNP	p	S91F	1	.	.	271	273	TTC	497	499	TTC	177;178;177	T;T;C	170;168;168	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5026	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3412	146.5	1	SNP	p	D95G	1	.	.	283	285	GGC	509	511	GGC	171;169;166	G;G;C	163;159;157	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5026	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3412	146.5	1	SNP	p	G95N	0	.	.	283	285	GGC	509	511	GGC	171;169;166	G;G;C	163;159;157	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1632	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1277	126.9	1	SNP	p	G45D	0	.	.	133	135	GGC	414	416	GGC	223;221;221	G;G,A;C	203;199,1;204	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	956	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1157	82.2	0	.	n	.	0	A197.	DEL	197	197	A	738	738	A	217	A	206	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4812	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2859	167.3	1	SNP	p	D86N	0	.	.	256	258	GAC	529	531	GAC	180;179;182	G;A;C	173;164;173	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4812	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2859	167.3	1	SNP	p	S87R	1	.	.	259	261	CGT	532	534	CGT	183;185;187	C;G;T	176;177;179	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4812	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2859	167.3	1	SNP	p	R87W	0	.	.	259	261	CGT	532	534	CGT	183;185;187	C;G;T	176;177;179	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4812	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2859	167.3	1	SNP	p	R87I	0	.	.	259	261	CGT	532	534	CGT	183;185;187	C;G;T	176;177;179	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4812	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2859	167.3	1	SNP	p	S88P	0	.	.	262	264	TCC	535	537	TCC	187;187;189	T;C;C	179;182;181	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4260	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2801	151.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1672	1674	GGC	205;202;198	G;G;C	190;190;185	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3960	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2429	162.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1252	1254	GCC	207;208;207	G;C;C	192;194;190	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3960	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2429	162.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1255	1257	ATG	210;215;214	A;T;G	193;199;196	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3960	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2429	162.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1267	1269	ACC	213;216;213	A;C;C	193;199;199	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3960	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2429	162.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1267	1269	ACC	213;216;213	A;C;C	193;199;199	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3960	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2429	162.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1768	1770	ACC	221;216;216	A,T;C;C	204,1;202;202	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3960	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2429	162.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1822	1824	GCG	218;213;213	G;C;G	197;194;194	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3960	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2429	162.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1822	1824	GCG	218;213;213	G;C;G	197;194;194	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3960	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2429	162.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1945	1947	GGT	172;170;169	G;G;T	161;158;155	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3960	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2429	162.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1954	1956	AGC	162;162;163	A;G;C	148;149;149	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3960	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2429	162.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1972	1974	CCG	141;143;141	C,G;C,G;G,T	112,5;115,1;116,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5520	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3073	178.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1637	1639	CCG	196;197;198	C;C;G	171;181;175	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2182	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1976	109.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	658	658	C	158	C	150	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2620	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1616	160.8	0	.	p	.	0	I45V	NONSYN	133	135	ATT	473	475	GTT	227;227;227	G;T;T	212;211;212	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2620	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1616	160.8	1	SNP	p	G120K	1	.	.	358	360	AAG	698	700	AAG	188;190;189	A;A;G	175;179;175	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2620	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1616	160.8	1	SNP	p	A121N	1	.	.	361	363	AAC	701	703	AAC	190;192;191	A;A;C	177;179;177	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2620	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1616	160.8	1	SNP	p	N121D	0	.	.	361	363	AAC	701	703	AAC	190;192;191	A;A;C	177;179;177	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10000	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4817	206.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	998	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1217	81.6	1	SNP	p	V57M	1	.	.	169	171	ATG	604	606	ATG	211;210;210	A;T,G;G	195;193,1;195	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
